Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Oct 3, 2011
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Award
Non-Qualified Stock Options (right to purchase)
2011-08-23$54.76/sh+500,000$27,380,000→ 4,765,489 totalExercise: $54.76From: 2015-08-23Exp: 2021-08-23→ Common Shares, no par value (500,000 underlying) - Award
Restricted Share Units
2011-08-23+120,000→ 1,125,994 total→ Common Shares, no par value (120,000 underlying)
Footnotes (5)
- [F1]Each Restricted Share Unit ("RSUs") represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (2).
- [F2]The performance based RSUs are eligible to vest on the achievement of certain TSR targets over a base price of $54.76. The 3-year TSR measurement period applicable to the vesting of the PSUs begins on the earlier of i) the common stock of the Company reaching a value of $54.76 (based on a 20-trading-day average), or ii) February 1, 2014.
- [F3]Includes 1,005,994 PSUs previously reported in Table II.
- [F4]The options vest 25% per year over 4 years with the first vest date on the first anniversary of the grant, the second vest date on the second anniversary of the grant, the third vest date on the third anniversary of the grant and the fourth vest date on the fourth anniversary of the grant.
- [F5]Includes 4,265,489 NQSOs previously reported in Table II.